AP Biosciences Inc (TPEX:6945)
Taiwan
· Delayed Price · Currency is TWD 52.80
-0.20 (-0.38%)
May 13, 2025, 1:08 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 4.54 billion as of May 13, 2025. Its market cap has increased by 14.16% in one year.
Market Cap
4.54B
Enterprise Value
2.87B
Revenue
32.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
52.80
Market Cap Chart
Since July 14, 2023, AP Biosciences's market cap has decreased from 5.10B to 4.54B, a decrease of -10.94%. That is a compound annual growth rate of -6.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 4.50B | 6.66% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 171.52B |
| Caliway Biopharmaceuticals | 110.55B |
| Bora Pharmaceuticals Co., LTD. | 74.21B |
| Lotus Pharmaceutical | 60.03B |
| Polaris Group | 33.16B |
| Oneness Biotech | 28.27B |
| Pegavision | 26.95B |
| Lumosa Therapeutics | 26.52B |